We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.8B
AUM Growth
+$23.3M
Cap. Flow
+$1.15M
Cap. Flow %
0.06%
Top 10 Hldgs %
63.1%
Holding
389
New
28
Increased
145
Reduced
135
Closed
38

Sector Composition

Rank Sector Weight
1 Industrials 3.03%
2 Consumer Discretionary 2.46%
3 Technology 1.96%
4 Financials 1.92%
5 Energy 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
201
TJX Companies
TJX
$179B
$442K 0.02%
9,292
-874
-9% -$38.4K
LOB icon
202
Live Oak Bancshares
LOB
$1.97B
$440K 0.02%
14,357
VBK icon
203
Vanguard Small-Cap Growth ETF
VBK
$22.9B
$438K 0.02%
2,494
-72
-3% -$12.3K
PSX icon
204
Phillips 66
PSX
$83.3B
$435K 0.02%
3,867
+954
+33% +$107K
NSC icon
205
Norfolk Southern
NSC
$75.4B
$430K 0.02%
2,852
+16
+0.6% +$2.34K
KDP icon
206
Keurig Dr Pepper
KDP
$42.3B
$428K 0.02%
3,513
+273
+8% +$32.8K
NGL icon
207
NGL Energy Partners
NGL
$1.87B
$420K 0.02%
33,569
-561
-2% -$6.58K
IEUS icon
208
iShares MSCI Europe Small-Cap ETF
IEUS
$176M
$419K 0.02%
7,454
SPPI
209
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$419K 0.02%
20,000
-10,000
-33% -$185K
XLK icon
210
State Street Technology Select Sector SPDR ETF
XLK
$111B
$413K 0.02%
11,888
-330
-3% -$11.3K
CVS icon
211
CVS Health
CVS
$136B
$412K 0.02%
6,399
+473
+8% +$31.2K
BIDU icon
212
Baidu
BIDU
$36.2B
$411K 0.02%
+1,691
New +$421K
AVA icon
213
Avista
AVA
$3.43B
$409K 0.02%
7,769
-283
-4% -$14.8K
GILD icon
214
Gilead Sciences
GILD
$166B
$400K 0.02%
5,640
-208
-4% -$14.7K
SHPG
215
DELISTED
Shire pic
SHPG
$399K 0.02%
2,370
-57
-2% -$9.19K
LLY icon
216
Eli Lilly
LLY
$1.09T
$394K 0.02%
4,618
+43
+0.9% +$3.53K
ELV icon
217
Elevance Health
ELV
$81.7B
$393K 0.02%
1,647
+210
+15% +$48.6K
ENZL icon
218
iShares MSCI New Zealand ETF
ENZL
$77.9M
$392K 0.02%
8,100
RY icon
219
Royal Bank of Canada
RY
$289B
$391K 0.02%
5,199
+110
+2% +$8.42K
TRV icon
220
Travelers Companies
TRV
$81.9B
$389K 0.02%
3,184
+49
+2% +$6.42K
MCK icon
221
McKesson
MCK
$105B
$381K 0.02%
+2,857
New +$418K
IVW icon
222
iShares S&P 500 Growth ETF
IVW
$71.6B
$377K 0.02%
9,280
+96
+1% +$3.86K
CMA
223
DELISTED
Comerica
CMA
$376K 0.02%
4,130
-14
-0.3% -$1.34K
PM icon
224
Philip Morris
PM
$311B
$373K 0.02%
4,615
+60
+1% +$5.09K
MDT icon
225
Medtronic
MDT
$112B
$372K 0.02%
4,351
-96
-2% -$8.02K

Similar funds

Ballentine Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Ballentine Partners held 389 positions worth $1.8B, up 1.3% from $1.78B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Ballentine Partners's Q2 2018 filing shows 28 new, 145 increased, 135 reduced and 38 closed positions. Its largest new stake was Baidu: 1,691 shares worth $411K. The largest sale was Coty, an estimated $5.39M.

By sector, the portfolio is most concentrated in Industrials at 3% of assets, down from 3.1% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Ballentine Partners's largest Q2 2018 buy was Baidu: 1,691 shares worth $411K.
  • Ballentine Partners added most to Vanguard Total Stock Market ETF in Q2 2018, an estimated $6.04M increase.
  • Ballentine Partners's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.67M.
  • Ballentine Partners fully exited Coty in Q2 2018, selling an estimated $5.39M.
  • Ballentine Partners's ten largest holdings make up 63% of its $1.8B portfolio in Q2 2018.
  • Ballentine Partners opened 28 new positions and closed 38 in Q2 2018.
  • Ballentine Partners's portfolio value rose 1.3% quarter-over-quarter to $1.8B.

Based on Ballentine Partners's 13F filing for Q2 2018, filed 19 Jul 2018.